Bone mineral density (BMD) assessment by using dual-energy X-ray absorptiometry (DXA) is the gold standard for diagnosis, monitoring and follow-up of bone mineral loss deficiencies such as osteoporosis and osteopenia. Generally speaking, DXA plays three main roles including diagnosis of osteoporosis, fracture risk assessment, and monitoring of treatment response (1). Studies have indicated that BMD measurement in hip and lumbar regions is the most reliable measurement for predicting hip fracture risk and spinal therapy monitoring respectively. In addition, DXA has several advantages including low scan times, easy to use, low radiation dose, and good measurement precision. However, although, DXA is a feasible approach for BMD assessment, it suffers from some limitations. For example, it is a two-dimensional (2D) imaging approach and areal density measurement is affected by bone size as well as the true 3D volumetric density of the bone tissue (2).
In addition to DXA, several other approaches are developed for BMD assessment. These methods are including quantitative computed tomography (QCT), peripheral DXA (pDXA), quantitative ultrasound (QUS) and magnetic resonance imaging (MRI) (3–5). Recently, quantitative radiomics texture analysis studies have been applied for a wide range of clinical applications such as diseases detection, diagnosis, prognosis and prediction (6–8). Although radiomics is used comprehensively for cancer studies, it is applicable for bone diseases management such as osteoporosis diagnosis and therapy response prediction and assessment. Previous studies have identified that radiomics features extracted from computed tomography (CT), magnetic resonance imaging (MRI) and radiology images could be used for bone diseases management (9, 10). In our previous study, we showed the feasibility of radiomics features extracted from DXA images to classify osteoporosis and osteopenia patients from normal ones (11).
Radiomics is an advanced image processing approach with several steps including image acquisition, segmentation, feature extraction, feature selection and data modelling (12–14). In radiomics approach, the extracted features could be served as imaging biomarker for diagnosis, prognosis, response prediction and assessment of therapy for several diseases. With this regard, radiomics features have to be reproducible, means that radiomics feature values should stay unchanged or minimally changed when the feature is computed from a repeat scan acquired after a short time interval. A wide range of studies have reported that radiomics features are vulnerable against changes in image acquisition, reconstruction, pre-processing, segmentation and analysis (15–17). In this light and to decrease false positive rate, robust radiomics features have to be found and used for further clinical applications.
Based on the previous radiomics studies, a reproducible/repeatable feature remain the same in different radiomics processes settings or in same radiomics processes, but in different times. To the best of our knowledge, there are no reports on BMD radiomics reproducibility over changes in the times of image accusation. In the present study, we aimed to assess the test-retest reproducibility of radiomics features extracted from DXA images. In this study, for first time, reproducibility of image features was checked in several regions of BMD images in two consecutive times. The reproducibility was calculated based on the statistical tests.